R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

ApackofR.J.Reynolds'newCamelCrushcigarettesforsaleinCaliforniaNicholasFlorko/STATWASHINGTON–Tobaccog MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef




hotspot

author：Wikipedia    Page View：48
Franklin faces
Adobe

ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

advertisement

Arch declined to comment on the new fundraising.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In
Previous article： Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry
Next article： What does generative AI mean for health care? We asked experts